No Data
No Data
Century Therapeutics, Inc.'s (NASDAQ:IPSC) Latest 25% Decline Adds to One-year Losses, Institutional Investors May Consider Drastic Measures
After Losing 17% in the Past Year, Century Therapeutics, Inc. (NASDAQ:IPSC) Institutional Owners Must Be Relieved by the Recent Gain
Century Therapeutics (IPSC) Moves to Buy: Rationale Behind the Upgrade
Century Therapeutics(IPSC.US) Officer Sells US$14,178.5 in Common Stock
Express News | Century Therapeutics Files For Shelf Of Up To 7.9M Shares Of Common Stock By Selling Stockholders
Express News | Century Therapeutics Inc Files for Shelf of up to 7.9 Mln Shares of Common Stock by Selling Stockholders - SEC Filing